--- title: "Exenatide vs SLU-PP-332: Side-by-Side Comparison (2026)" url: https://www.bodyhackguide.co/compare/exenatide-vs-slu-pp-332 description: "Compare Exenatide vs SLU-PP-332 side by side. We earn a commission on some vendor links. Mechanism, half-life, dose range, side effects and prices." lang: en --- Skip to content Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide) # Exenatide vs SLU-PP-332 Side-by-side comparison of Exenatide and SLU-PP-332: mechanism, half-life, dose range, safety profile, and vendor pricing. Exenatide: no price on file SLU-PP-332 from $69.99 ## Price snapshot ### Exenatide Current low — 7-day low — not enough history yet 30-day low — not enough history yet 30-day change — not enough history yet ### SLU-PP-332 Current low $69.99 current listings 7-day low — not enough history yet 30-day low — not enough history yet 30-day change — not enough history yet ## Exenatide Exenatide (Byetta, Bydureon) is a synthetic exendin-4 GLP-1 receptor agonist, FDA-approved for type 2 diabetes, that lowers blood glucose and curbs appetite. Available as a twice-daily immediate-release and a once-weekly… No vendor price on file. Full Exenatide profile (https://www.bodyhackguide.co/compound/exenatide) ## SLU-PP-332 SLU-PP-332 is the first-generation synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ) developed by the laboratory of Thomas Burris at Saint Louis University and reported in a landmark 2023… **Lowest listed price:** $69.99 across 5 listings Full SLU-PP-332 profile (https://www.bodyhackguide.co/compound/slu-pp-332) ## Side-by-side comparison | Attribute | Exenatide | SLU-PP-332 | | --- | --- | --- | | Category | Weight Loss | Performance | | Research Stage | FDA-approved | Preclinical | | Mechanism of Action | Exenatide is a synthetic form of exendin-4, a 39-amino-acid peptide first isolated from the saliva of the Gila monster (Heloderma suspectum). It shares about 53 percent of its sequence with human GLP-1 but, unlike native GLP-1, resists breakdown by the DPP-4… | SLU-PP-332 acts through pan-agonism of the three estrogen-related receptors (ERRα/NR3B1, ERRβ/NR3B2, ERRγ/NR3B3), a subfamily of orphan nuclear receptors that regulate oxidative metabolism, mitochondrial biogenesis, and exercise-responsive gene expression. The… | | Half-Life | Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks. | — | | Typical Dose Range | 5 to 10 mcg twice daily (Byetta, immediate-release) or 2000 mcg (2 mg) once weekly (Bydureon, extended-release) | Research compound — no established human doses. Animal studies: 10-50 mg/kg | | Dosing Frequency | Twice daily before meals (immediate-release) or once weekly (extended-release) | — | | Administration | — | — | | Side Effects | Gastrointestinal effects are by far the most common: nausea (reported in roughly 40 to 57 percent of patients on the twice-daily form, usually worst early and fading over weeks), vomiting, diarrhea, constipation, and dyspepsia. Reduced appetite is expected.… | The side effect profile of SLU-PP-332 in humans is undocumented because no clinical trials have been conducted. Rodent studies report generally acceptable tolerability at doses producing exercise-mimetic metabolic effects, without overt signs of toxicity on… | | Molecular Weight | 4186.6 g/mol (molecular formula C184H282N50O60S) | 535.54 g/mol | | Common Vial Sizes | — | — | ## Price History 3 data points - Half Nattys - Ion Peptide - BHG Labs ### Exenatide: potential benefits - Meaningful glycemic control in type 2 diabetes, with HbA1c reductions of roughly 1.0 to 1.9 percent in randomized trials - Weight reduction of about 2 to 3 kg in diabetic trials, driven mainly by reduced appetite and slower gastric emptying - Low intrinsic hypoglycemia risk because insulin release is glucose-dependent (risk rises when combined with sulfonylureas or insulin) - Strong control of post-meal glucose spikes - Cardiovascular safety shown in a large outcomes trial, with no increase in major cardiac events - Can be added to basal insulin to improve control while offsetting insulin-related weight gain - Once-weekly extended-release option (Bydureon) reduces injection burden versus twice-daily dosing - In people without diabetes the appetite effect is real, but standalone weight loss has been modest and less consistent than newer agents such as [semaglutide](/compound/semaglutide) or [tirzepatide](/compound/tirzepatide) ### SLU-PP-332: potential benefits - Exercise mimicry without physical exertion - Enhanced fat oxidation - Increased mitochondrial biogenesis - Improved endurance capacity - Muscle fiber type conversion - Metabolic health improvement ## Frequently asked ### What's the difference between Exenatide and SLU-PP-332? Exenatide is a weight loss that exenatide is a synthetic form of exendin-4, a 39-amino-acid peptide first isolated from the saliva of the gila monster (heloderma suspectum). it shares about 53 percent of its…. SLU-PP-332 is a performance that slu-pp-332 acts through pan-agonism of the three estrogen-related receptors (errα/nr3b1, errβ/nr3b2, errγ/nr3b3), a subfamily of orphan nuclear receptors that regulate oxidative…. The two differ in mechanism, half-life (Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks. vs not reported), and typical dose range. ### Which has the longer half-life, Exenatide or SLU-PP-332? Exenatide has a half-life of Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks.. SLU-PP-332 has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics. ### Can you stack Exenatide and SLU-PP-332? Stacking depends on mechanism overlap, safety profile, and goals. Exenatide and SLU-PP-332 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds. ## See current vendor prices Listings from the vendors we track. Prices change often, so check the vendor before you buy. Exenatide prices: https://www.bodyhackguide.co/compound/exenatide?tab=prices SLU-PP-332 prices: https://www.bodyhackguide.co/compound/slu-pp-332?tab=prices Compare all compounds: https://www.bodyhackguide.co/compare ### Before you buy Exenatide or SLU-PP-332 Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor. View Vendor Scorecard (https://www.bodyhackguide.co/vendors/scorecard) ## Related comparisons **Research use only.** BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards (https://www.bodyhackguide.co/editorial-standards) and affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). BodyHackGuide (https://www.bodyhackguide.co/) Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews. support@bodyhackguide.co Join our Discord: https://discord.gg/Mhq5UdRYBA r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide **Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology). Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. - Terms: https://www.bodyhackguide.co/terms - Privacy: https://www.bodyhackguide.co/privacy ## Structured data ```json [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Exenatide vs SLU-PP-332" } ] }, { "@context": "https://schema.org", "@type": "WebPage", "name": "Exenatide vs SLU-PP-332: Side-by-Side Comparison (2026)", "description": "Compare Exenatide vs SLU-PP-332 side by side. We earn a commission on some vendor links. Mechanism, half-life, dose range, side effects and prices.", "url": "https://www.bodyhackguide.co/compare/exenatide-vs-slu-pp-332", "dateModified": "2026-10-26", "isPartOf": { "@type": "WebSite", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainEntity": { "@type": "ItemList", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@type": "Product", "name": "Exenatide", "description": "Exenatide (Byetta, Bydureon) is a synthetic exendin-4 GLP-1 receptor agonist, FDA-approved for type 2 diabetes, that lowers blood glucose and curbs appetite. Available as a twice-daily immediate-release and a once-weekly extended-release injection.", "url": "https://www.bodyhackguide.co/compound/exenatide", "category": "Weight Loss" } }, { "@type": "ListItem", "position": 2, "item": { "@type": "Product", "name": "SLU-PP-332", "description": "SLU-PP-332 is the first-generation synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ) developed by the laboratory of Thomas Burris at Saint Louis University and reported in a landmark 2023 publication that established ERR pan-agonism as a pharmacologically tractable…", "url": "https://www.bodyhackguide.co/compound/slu-pp-332", "category": "Performance", "offers": { "@type": "AggregateOffer", "lowPrice": "69.99", "priceCurrency": "USD", "offerCount": 5 } } } ] } }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 273 compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. We earn a commission on purchases through some of our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What's the difference between Exenatide and SLU-PP-332?", "acceptedAnswer": { "@type": "Answer", "text": "Exenatide is a weight loss that exenatide is a synthetic form of exendin-4, a 39-amino-acid peptide first isolated from the saliva of the gila monster (heloderma suspectum). it shares about 53 percent of its…. SLU-PP-332 is a performance that slu-pp-332 acts through pan-agonism of the three estrogen-related receptors (errα/nr3b1, errβ/nr3b2, errγ/nr3b3), a subfamily of orphan nuclear receptors that regulate oxidative…. The two differ in mechanism, half-life (Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks. vs not reported), and typical dose range." } }, { "@type": "Question", "name": "Which has the longer half-life, Exenatide or SLU-PP-332?", "acceptedAnswer": { "@type": "Answer", "text": "Exenatide has a half-life of Immediate-release (Byetta): terminal half-life about 2.4 hours, cleared mainly by the kidneys. Extended-release (Bydureon): the same peptide is released slowly from biodegradable microspheres over roughly 10 weeks, reaching steady-state plasma levels by about 6 to 7 weeks.. SLU-PP-332 has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics." } }, { "@type": "Question", "name": "Can you stack Exenatide and SLU-PP-332?", "acceptedAnswer": { "@type": "Answer", "text": "Stacking depends on mechanism overlap, safety profile, and goals. Exenatide and SLU-PP-332 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds." } } ] } ] ```